Inhibitors
- NBQX disodium salt [orb1611084 ]
>98%
[479347-86-9]
380.24
C12H6N4Na2O6S
O=C([N-]1)C([N-]C2=C1C3=C(C([N+]([O-])=O)=C2)C(S(N)(=O)=O)=CC=C3)=O.[Na+].[Na+]
100 mg, 250 mg, 1 g -
- NewMSI-1436 [orb611475]
[186139-09-3]
685.0564
C37H72N4O5S
NCCCNCCCCNCCCNC1CCC2(C)C3(CCC4(C([H])(C(CCC(C(C)C)OS(=O)(O)=O)C)CCC4([H])C3([H])C(O)CC2([H])C1)C)[H]
5 mg, 10 mg, 50 mg - NewAQX 1125 [orb611583]
[782487-28-9]
321.505
C20H35NO2
C[C@@]1(CC[C@@H](C[C@@H]1CO)O)[C@H]2CC[C@]3([C@H]([C@@H]2CN)CCC3=C)C
100 mg, 250 mg, 1 g - NewDapansutrile(OLT1177) [orb757695]
[54863-37-5]
133.17
C4H7NO2S
N#CCCS(=O)(C)=O
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - NewDasotraline(SEP-225289) free base [orb757701]
[675126-05-3]
292.203
C16H15NCL2
ClC1C(Cl)=CC(=CC=1)[C@H]2C3C(=CC=CC=3)[C@H](N)CC2
100 mg, 250 mg, 1 g - NewMavatrep(JNJ-39439335) [orb1089318]
[956274-94-5]
422.4423
C25N2OF3H21
OC(C)(C)C1=CC=CC=C1C2=CC=C3N=C(/C=C/C4=CC=C(C(F)(F)F)C=C4)NC3=C2
100 mg, 250 mg, 1 g - NewTCN-201 [orb1089319]
[852918-02-6]
461.89
C21H17ClFN3O4S
O=C(NNC(C1=CC=CC=C1)=O)C2=CC=C(CNS(=O)(C3=CC=C(F)C(Cl)=C3)=O)C=C2
100 mg, 250 mg, 1 g - NewCDK4 inhibitor compound 12 [orb1089320]
[2105956-77-0]
639.72242975235
C34H38FN9O3
C1(NC2=NC=C(N3CCN(C(C4(C(NC5=CC=C(F)C=C5)=O)CC4)=O)CC3)C=C2)=NC=C2C=C(C(N(C)C)=O)N(C3CCCC3)C2=N1
50 mg - NewNS-3623 [orb1089321]
[343630-41-1]
427.185
C15H10BrF3N6O
O=C(NC1C=C(C=CC=1)C(F)(F)F)NC2=C(C=C(Br)C=C2)C3N=NNN=3
100 mg, 250 mg, 1 g